Cowin Venture

Cowin Venture is an angel and early-stage investor in TMT and Healthcare.

Business Model:

Revenue: $0

Employees: 0-0

Rankings

Detailed Cowin Venture Information

Geographic Data

Cowin Venture headquarters map

Address: No 38 East Third Ring Road

City: Beijing

State: beijing municipality

Zip: 100010

Country: CN

Financial Info

Stage:

Raised Last:

$0

Raised Total:

$150M

Metrics

6,357,281Website Global Rank

969Website Monthly Traffic

Twitter Followers

Description

Founded in 2009, Cowin Venture is an angel and early-stage investor in TMT and Healthcare. We keep nurturing growth-stage companies graduated from their angel investment portfolio. Cowin’s business network covers China and USA. They have offices in Suzhou, Nanjing, Shanghai, Beijing and Hong Kong.

Contact Phone:

Contact Email:

Announced Date Company Transaction Money Raised
3/2022 Celsius Therapeutics Series B 0
9/2021 FORQALY Series B -
11/2017 TETRA ELC Series A 1.5M
1/2018 Sinovation Medical Series A 0
12/2016 TETRA ELC Angel Round 1.5M
9/2022 Mesai Biotech Series A -
1/2016 Yidu Yuanqi Angel Round 459.2k
7/2018 Neighboring good doctors Series A -
5/2022 Supervision Technology Seed Round 0
2/2021 Immorna Series A 15.5M
12/2010 Jia.com Series A 41.5M
4/2020 Tuxing Keji Seed Round 1.4M
12/2022 Sinovation Medical Series D 43.1M
6/2018 Aidong Super AI Angel Round 458.7k
10/2016 Linked-F Series A 3.3M
12/2015 Leads Biolabs Angel Round -
10/2019 Taimei Technology Series E 211.8M
10/2022 Xindi Digital Engineering System Venture Round 96.8M
10/2019 GeneCast Biotechnology Series D 42.5M
9/2018 Aidong Super AI Series A 1.5M
12/2013 Howsome Series A 1.6M
9/2017 Paragon Genomics, Inc. Series A 8M
3/2022 Arima Genomics Series B 0
6/2014 PegBio Series B -
5/2018 Neucyte, Inc. Series A 6.7M
8/2022 Jade Bird Display Series A -
10/2015 Lightning Expense Series A 1.6M
4/2020 Luxin DB Software Angel Round -
6/2014 Taimei Technology Angel Round -
7/2018 NeighBor Doc Series A 3M
7/2020 Rapid Novor Series A 5M
3/2021 Aucta Pharmaceuticals China Series A -
10/2021 Raypaitech Series A 1.5M
3/2012 DeeSha Angel Round 473.9k
5/2017 AMT Series E 7.2M
1/2022 Amberstone Biosciences Series A 0
2/2020 Arima Genomics Series A -
4/2020 BennuBio Series B 0
1/2017 Taimei Technology Series C 14.5M
11/2016 NeighBor Doc Seed Round 1.5M
8/2018 Luxin Technology (Lu-Semi) Series A -
2/2021 Bioelectronica Series A -
7/2017 Leads Biolabs Series A -
2/2018 GeneCast Biotechnology Series C 33M
9/2020 Taimei Technology Venture Round 0
6/2022 Degron Therapeutics Series A 0
12/2021 Amador Bioscience Series B 60M
1/2020 Fluent BioSciences Series A 0
2/2022 Ucello Therapeutics Series A 0
1/2018 Zhong Fangdingqi Angel Round 473.4k
3/2021 Neuracle Series B -
6/2016 Taimei Technology Series B -
8/2021 Neuexcell Therapeutics Pre-Series A 10M
9/2021 Amador Bioscience Series B -
4/2018 Taimei Technology Series D 47.8M
7/2020 Thrive Earlier Detection Series B 0
12/2017 Meijun Electronic Angel Round -
7/2021 Hongyun Biotech Series B 15.4M
1/2019 Taimei Technology Series E 80M
7/2016 Synbio Technologies Series B 3M
8/2015 Fangcun Doctor Angel Round 468.2k
5/2019 Thrive Earlier Detection Series A 110M
6/2022 Degron Therapeutics Series A 0
5/2022 Supervision Technology Seed Round 0
3/2022 Celsius Therapeutics Series B 0
3/2022 Arima Genomics Series B 0
2/2022 Ucello Therapeutics Series A 0
1/2022 Amberstone Biosciences Series A 0
12/2021 Amador Bioscience Series B 0
10/2021 Raypaitech Series A 0
9/2021 FORQALY Series B -
9/2021 Amador Bioscience Series B -

Startup Industries

Startup Locations

Portfolio Current Status

Portfolio Employee Count

Name Price
Name Size Announced Date

You know, we could be doing all this for you..

CoBee's Logo

Be ahead of your competition

  • Realtime intelligence
  • Automated contact tracking
  • Unmatched insights
  • Eliminate manual research